Explore more publications!

New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on March 16, 2026

Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026
Poison Prevention Week – Thinking beyond the Obvious
Tobias Burkhardt’s Paretofit Reports 98.1% Success Rate Across 169 Entrepreneur Coaching Engagements
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value
Qolab Announces John Martinis Prize as Momentum Builds for Scalable Quantum Hardware
Alpha Tau to Present at Sidoti March Virtual Small Cap Conference
Nordletics Makes Home Fitness Simple and Personalized
Lucia Gaitan, M.D., FACOG, First in Miami to Offer Cerene® Endometrial Cryotherapy for Women with Heavy Periods
Nadia Care Raises $12 Million to Expand Community-Centered Maternal Care Model Across the U.S.
Archer Property Partners Acquires MemorialCare-Anchored Orange County Medical Office Portfolio in Off-Market Deal
Radiant Health Centers Announces CEO Transition
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
NorthStar Moving & Move For Hunger Help Feed the Community After the 2026 Los Angeles Marathon
PROLLENIUM® Launches VAMP™ Advanced, a Patent-Pending PDRN Solution
Solve GNE Highlights New Research, Expands Funding Efforts, and Advances Toward a Phase I Clinical Trial for GNE Myopathy
Prodeon Medical Receives FDA 510(k) Clearance for the Urocross® Expander System, a Novel Non-Permanent Retrievable Implant for Treating Urinary Symptoms Associated with Benign Prostatic Hyperplasia
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT)
Amlogenyx Announces Positive Preclinical Data on AM805, a Potent Amyloid-Degrading Protease for the Treatment of Alzheimer’s Disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions